Atopic Dermatitis (AD) is an extremely pruritic inflammatory skin disease that has a
worldwide prevalence of approximately 2.69%, with significant variability by country. 1 In the …

Atopic dermatitis (AD) is a global condition that has a rising prevalence in developing
countries such as those within South-east Asia and Latin America. Recent research …

The number of clinical trials conducted in patients with atopic dermatitis is increasing
steadily. These trials are conducted in several countries across all continents and include …

Background The prevalence and burden of atopic dermatitis (AD) are disproportionately
high in individuals with skin of colour (SOC). Previous research shows that risk for xerosis …

Background: Current guidance for using Eczema Area and Severity Index (EASI)
implementation is limited to lighter skin phototypes. We developed an EASI lesion severity …

Skin is the calling card of humanity—the body's first line of defense against external threats
and a major part of a person's identity. Diseases of the skin are common and a leading …

Abstract Background/Objectives We sought to quantify the reliability and validity of remote
atopic dermatitis (AD) severity assessment using the Eczema Area and Severity Index …

2. Apalla Z, Nikolaou V, Fattore D, et al. European recommendations for management of
immune checkpoint inhibitors-derived dermatologic adverse events. The EADV task …

Black and Latinx children have disparities in health conditions and associated outcomes
when compared to white children, including atopic dermatitis (AD). This dissertation is a …

Variation in the clinical presentation of atopic dermatitis in adults across self-identified racial
categories: a single-center, cross-sectional study in an academic tertiary care center. - Abstract …